Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL960865 | 0.79 | THRB (0.42) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL60085 | 0.78 | THRB (0.65) | THRBTSHRALDH1A1POLBAPEX1 | |
| Cyclohexane SCHEMBL117214 | 0.78 | THRB (0.65) | THRBTSHRALDH1A1POLBAPEX1 | |
| Cyclopentane SCHEMBL2397167 | 0.78 | THRB (0.65) | THRBTSHRALDH1A1POLBAPEX1 | |
| Cyclopropane SCHEMBL420362 | 0.78 | THRB (0.65) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL148593 | 0.78 | THRB (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL153853 | 0.78 | THRB (0.41) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL28481187 | 0.76 | THRB (0.40) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL936916 | 0.75 | THRB (0.42) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL27501921 | 0.75 | TSHR (0.49) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10285914-B2 | Bonding method, bonding kit, and bonding material | TOKUYAMA DENTAL CORPORATION (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20170156991-A1 | BONDING METHOD, BONDING KIT, AND BONDING MATERIAL | TOKUYAMA DENTAL CORPORATION (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20170156991-A1 | BONDING METHOD, BONDING KIT, AND BONDING MATERIAL | TOKUYAMA DENTAL CORPORATION (JP) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10285914-B2 | Bonding method, bonding kit, and bonding material | SUV39H1, SUV39H2, EZH1 | THRB 3991/4885TSHR 4547/4885ALDH1A1 946/4885 |
| US-20170156991-A1 | BONDING METHOD, BONDING KIT, AND BONDING MATERIAL | SUV39H1, SUV39H2, EZH1 | THRB 3991/4885TSHR 4547/4885ALDH1A1 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.